Gene · 79679
Papers2,409
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,409
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Regulation of Cancer Stem Cells in the Tumor Microenvironment. | Cancer Heterog Plast | 2025 | 41868064 | PubTator, text mining | PubMed |
| An immune checkpoint-based score is a prognostic marker in retrospective cohort study of patients with gastric cancer. | Transl Cancer Res | 2025 | 41510089 | PubTator, text mining | PubMed |
| CCL18: a potential immunosuppressive biomarker for prognosis in ABC diffuse large B-cell lymphoma. | Front Immunol | 2025 | 41472741 | PubTator, text mining | PubMed |
| Expression of antibody-drug conjugate targets in post-mortem samples of breast cancer metastases and normal tissue. | Nat Commun | 2025 | 41449182 | PubTator, text mining | PubMed |
| Immunological mechanisms and antibody-drug conjugates targeting B7-H3 and B7-H4 in ovarian cancer. | Front Immunol | 2025 | 41357243 | PubTator, text mining | PubMed |
| Exploration of oxidative stress-related molecular signature for clear cell renal cell carcinoma. | Discov Oncol | 2025 | 41313400 | PubTator, text mining | PubMed |
| Ultrasensitive multiplex detection of lung cancer EV-associated immune checkpoints using a mesoporous gold enhanced SERS biosensor. | Nanoscale | 2025 | 41313229 | PubTator, text mining | PubMed |
| EVOLVE platform, a trispecific T cell engager with integrated CD2 costimulation, for the treatment of solid and hematologic tumors. | Proc Natl Acad Sci U S A | 2025 | 41252152 | PubTator, text mining | PubMed |
| Clinical significance of B7-H4 expression in ovarian cancer: a meta-analysis of proportions and time-to-event survival outcomes. | Cell Mol Biol (Noisy-le-grand) | 2025 | 41236299 | PubTator, text mining | PubMed |
| The role of immune checkpoints in modulating cancer stem cells anti-tumor immune responses: implications and perspectives in cancer therapy. | J Exp Clin Cancer Res | 2025 | 41233805 | PubTator, text mining | PubMed |
| Immune Checkpoint Therapy for Thymic Carcinoma. | Cancers (Basel) | 2025 | 41154432 | PubTator, text mining | PubMed |
| A novel B7-H4/CD3/CD28 trispecific antibody with the SpyTag-SpyCatcher technology suppresses the growth of colorectal cancer. | Int Immunopharmacol | 2025 | 41138305 | PubTator, text mining | PubMed |
| Clinicopathological features and prognostic value of B7x expression in female reproductive system malignancies: A meta-analysis. | Medicine (Baltimore) | 2025 | 41137330 | PubTator, text mining | PubMed |
| Prognostic Signature of NETs-Related Genes in Hepatocellular Carcinoma Based on Bulk and Single-Cell Transcriptomics. | J Hepatocell Carcinoma | 2025 | 41116903 | PubTator, text mining | PubMed |
| Immune checkpoint biology in hepatocellular carcinoma (Review). | Oncol Lett | 2025 | 41112836 | PubTator, text mining | PubMed |
| Spatial domain identification method based on multi-view graph convolutional network and contrastive learning. | PLoS Comput Biol | 2025 | 41105750 | PubTator, text mining | PubMed |
| Comparison of imaging based single-cell resolution spatial transcriptomics profiling platforms using formalin-fixed paraffin-embedded tumor samples. | Nat Commun | 2025 | 41006245 | PubTator, text mining | PubMed |
| The B7 family molecules in oral squamous cell carcinoma: a systematic review. Part II: B7-1, B7-2, B7-H2, B7-H3, B7-H4, B7-H5 (VISTA), B7-H6 and B7-H7. | Postepy Dermatol Alergol | 2025 | 41001137 | PubTator, text mining | PubMed |
| Unlocking new frontiers: novel immune targets for next-generation cancer immunotherapy. | Korean J Clin Oncol | 2025 | 40916400 | PubTator, text mining | PubMed |
| MALAT1 Expression Is Deregulated in miR-34a Knockout Cell Lines. | Noncoding RNA | 2025 | 40863726 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/79679/papers?page=5